143 related articles for article (PubMed ID: 2551540)
1. Immunoradiometric assay for alpha gamma- and gamma gamma-enolase (neuron-specific enolase), with use of monoclonal antibodies and magnetizable polymer particles.
Paus E; Nustad K
Clin Chem; 1989 Oct; 35(10):2034-8. PubMed ID: 2551540
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal immunoradiometric assay and polyclonal radioimmunoassay compared for measuring neuron-specific enolase in patients with lung cancer.
Body JJ; Paesmans M; Sculier JP; Dabouis G; Bureau G; Libert P; Berchier MC; Raymakers N; Klastersky J
Clin Chem; 1992 May; 38(5):748-51. PubMed ID: 1316245
[TBL] [Abstract][Full Text] [Related]
3. Establishment and evaluation of a radioimmunoassay for neuron-specific enolase. A marker for small cell lung cancer.
Paus E; Risberg T
Tumour Biol; 1989; 10(1):23-30. PubMed ID: 2538916
[TBL] [Abstract][Full Text] [Related]
4. Immunoradiometric assay of chromogranin A in the diagnosis of small cell lung cancer: comparative evaluation with neuron-specific enolase.
Giovanella L; Ceriani L; Bandera M; Garancini S
Int J Biol Markers; 2001; 16(1):50-5. PubMed ID: 11288956
[TBL] [Abstract][Full Text] [Related]
5. Neuron specific enolase (NSE) in serum of patients with malignant melanoma.
Wibe E; Paus E; Aamdal S
Cancer Lett; 1990 Jun; 52(1):29-31. PubMed ID: 2354416
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a new IRMA method for the determination of neuron specific enolase.
Mione R; Bombardieri E; Gion M; Gatti C; Bruscagnin G
Int J Biol Markers; 1990; 5(3):155-6. PubMed ID: 1962809
[No Abstract] [Full Text] [Related]
7. Evaluation of "neuron-specific enolase" as a tumor marker for small cell carcinoma of the lung.
Güner G; Oktay G; Akkoçlu A; Karlikaya C
Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):306S. PubMed ID: 8224452
[No Abstract] [Full Text] [Related]
8. Serum levels of neuron-specific enolase, carbohydrate antigen 19-9 and carbohydrate antigen 125 in carcinoma of the lung.
Oktay G; Güner G; Karlikaya C; Akkoçlu A
Biochem Soc Trans; 1995 May; 23(2):211S. PubMed ID: 7672232
[No Abstract] [Full Text] [Related]
9. Serum neurone-specific enolase and other neuroendocrine markers in lung cancer.
Ledermann JA
Eur J Cancer; 1994; 30A(5):574-6. PubMed ID: 8080666
[No Abstract] [Full Text] [Related]
10. The diagnostic value of neuron-specific enolase and carcino-embryonic antigen analyses in patients with carcinoma of the lung.
Wielders JP; Bartels CT; Bank CM; Meek JC; van Dieijen-Visser MP; Brombacher PJ
J Clin Chem Clin Biochem; 1990 Apr; 28(4):225-31. PubMed ID: 2162907
[TBL] [Abstract][Full Text] [Related]
11. Neuron-specific enolase (NSE) in serum. Comparison of monoclonal versus polyclonal assay based on 392 blood samples.
Drivsholm L; Osterlind K; Cooper EH; Purves DA
Int J Biol Markers; 1995; 10(1):1-4. PubMed ID: 7629420
[TBL] [Abstract][Full Text] [Related]
12. Enzymatic determination of serum neuron-specific enolase in small cell lung cancers. Utility of the serum neuron-specific enolase/serum nonneuronal enolase ratio.
Viallard JL; Caillaud D; Kantelip B; Molina C; Dastugue B
Chest; 1988 Jun; 93(6):1225-33. PubMed ID: 2836136
[TBL] [Abstract][Full Text] [Related]
13. Expression and interconversion of neuron-specific enolase in patient sera and extracts from small-cell lung cancer cells.
Paus E; Myklebust AT
Tumour Biol; 1996; 17(5):271-80. PubMed ID: 8792853
[TBL] [Abstract][Full Text] [Related]
14. Brain-specific proteins: solid-phase immunobioluminescence assay for neuron-specific enolase in human plasma.
Gerbitz KD; Summer J; Thallemer J
Clin Chem; 1984 Mar; 30(3):382-6. PubMed ID: 6321057
[TBL] [Abstract][Full Text] [Related]
15. Technical performance and diagnostic utility of the new Elecsys neuron-specific enolase enzyme immunoassay.
Muley T; Ebert W; Stieber P; Raith H; Holdenrieder S; Nagel D; Fürst H; Roth HJ; Luthe H; Blijenberg BG; Gurr E; Uhl W; von Pawel J; Drings P
Clin Chem Lab Med; 2003 Jan; 41(1):95-103. PubMed ID: 12636057
[TBL] [Abstract][Full Text] [Related]
16. Comparison of neurone-specific enolase and pro-gastrin releasing peptide in the prognostic evaluation of small cell lung cancer patients.
Satoh H; Kagohashi K; Kurishima K; Ishikawa H; Ohtsuka M
Clin Oncol (R Coll Radiol); 2006 Nov; 18(9):720. PubMed ID: 17100161
[No Abstract] [Full Text] [Related]
17. Enzyme-linked immunosorbent assay of pro-gastrin-releasing peptide for small cell lung cancer patients in comparison with neuron-specific enolase measurement.
Yamaguchi K; Aoyagi K; Urakami K; Fukutani T; Maki N; Yamamoto S; Otsubo K; Miyake Y; Kodama T
Jpn J Cancer Res; 1995 Jul; 86(7):698-705. PubMed ID: 7559089
[TBL] [Abstract][Full Text] [Related]
18. Performance characteristics of seven neuron-specific enolase assays.
Stern P; Bartos V; Uhrova J; Bezdickova D; Vanickova Z; Tichy V; Pelinkova K; Prusa R; Zima T
Tumour Biol; 2007; 28(2):84-92. PubMed ID: 17259755
[TBL] [Abstract][Full Text] [Related]
19. Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer.
Burghuber OC; Worofka B; Schernthaner G; Vetter N; Neumann M; Dudczak R; Kuzmits R
Cancer; 1990 Mar; 65(6):1386-90. PubMed ID: 2155054
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of gamma-enolase as a tumor marker for lung cancer.
Fujita K; Haimoto H; Imaizumi M; Abe T; Kato K
Cancer; 1987 Aug; 60(3):362-9. PubMed ID: 3036329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
